TD Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-126,049
Closed -$19.3M 1628
2021
Q1
$19.3M Sell
126,049
-98,851
-44% -$13.4M 0.02% 474
2020
Q4
$28.2M Buy
224,900
+28,000
+14% +$3.13M 0.03% 361
2020
Q3
$20M Buy
196,900
+6,000
+3% +$612K 0.03% 395
2020
Q2
$18.6M Buy
190,900
+13,900
+8% +$1.29M 0.03% 376
2020
Q1
$14.7M Buy
177,000
+11,600
+7% +$1.13M 0.02% 389
2019
Q4
$18.4M Buy
165,400
+11,000
+7% +$1.13M 0.03% 401
2019
Q3
$15.3M Buy
154,400
+56,100
+57% +$5.57M 0.02% 415
2019
Q2
$9.75M Buy
+98,300
New +$9.38M 0.01% 533

Other funds holding PRAH

TD Asset Management's PRAH Position: Q2 2021 in Review

TD Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 126,049 shares — an estimated $19.3M sold.

TD Asset Management first reported a position in PRAH in Q2 2019 and held it in 8 quarters. The position peaked at $28.2M in Q4 2020. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • TD Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • TD Asset Management sold 126,049 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $19.3M.
  • TD Asset Management first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 8 quarters.
  • TD Asset Management's PRA Health Sciences, Inc. position peaked at $28.2M in Q4 2020.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on TD Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.